大阪医科薬科大学 · 泌尿生殖・発達医学講座 · 助教

研究关键词prostate cancer・urothelial carcinoma・androgen receptor inhibitors・immunotherapy outcomes・metastatic burden・tumor microenvironment

研究领域泌尿器科学

以下为公开数据预览。个性化匹配理由、联系角度和保存能力需要登录后使用。

• Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.2026 · Japanese journal of clinical oncology
• Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.2026 · BJU international / 137 / 2
• Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.2026 · Japanese journal of clinical oncology
• Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.2026 · Japanese journal of clinical oncology / 56 / 1

• 官方个人主页